치료 HIV 대상 초기 임상 시험서 97% 효과…‘에이즈 백신’ 나오나
페이지 정보
본문
“eOD-GT8 60me, 8주 간격 2차례 접종시 HIV 면역반응 유도”
“백신 상용화 성공시 HIV 연구 40년만에 성공한 첫 백신 된다”
모더나도 mRNA 기반 HIV 백신 후보 ‘mRNA-1644’ 개발 중기사 바로가기출처: 세계일보
This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data.
You can email the site owner to let them know you were blocked. Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page.
종로센터 : 서울시 종로구 인사동길 17, 5층 ㆍTel.02-792-0083 ㆍFax.02-744-9118
부산센터 : 부산시 동구 범일로 101-4, 2층 ㆍTel.051-646-8088 ㆍFax.051-646-8089
이태원센터 : 서울시 용산구 우사단로33, 3층 ㆍTel.02-749-1107 ㆍFax.02-749-1109
This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data.
You can email the site owner to let them know you were blocked. Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page.